Funding Briefs

Persons trained as medical doctors have traditionally played an important role in advancing the frontiers of biomedical research. But the need to pay medical education debts and the competition for funding have pushed many potential researchers away from the laboratory and into clinical practice. Enter the Howard Hughes Medical Institute. HHMI has just launched a postdoctoral research fellowship program to encourage clinically trained M.D.'s to pursue careers in research. Each year the program w

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Enter the Howard Hughes Medical Institute. HHMI has just launched a postdoctoral research fellowship program to encourage clinically trained M.D.'s to pursue careers in research. Each year the program will support up to 25 fellows with annual stipends ranging from $35,000 to $50,000 and an additional $17,000 in institutional and personal allowances. The stipends run for three years and will be awarded to M.D.'s who have completed their clinical training and who wish to conduct research at the institution of their choice.

The Bethesda, Md.-based institute, established in 1953, has an endowment approaching $5 billion. Although it has funded a network of senior investigators for many years, only in the past few years has it begun to confront directly the pending shortage of biomedical scientists in the next generation. Its current programs concentrate on undergraduate- and graduate-level training, and HHMI officials expect future efforts to encompass the precollege and health ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies